| MP:0002412 | increased susceptibility to bacterial infection | "greater likelihood that an organism will develop ill effects from a bacterial infection or from components of or toxins produced by bacteria" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Ap1s2tm1Pschu/Y
Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
| MP:0005011 | increased eosinophil count | "greater than normal eosinophil numbers" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Ap1s2tm1Pschu/Y
Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
| MP:0008090 | increased T-helper 2 cell number | "greater number of the subset of the type of T-helper cell whose cytokine production promotes defense against extracellular parasites and humoral immune responses typical of allergy" [CL:0000546, ISBN:0781735149, MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ap1s2tm1Pschu/Y
Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
| MP:0008537 | increased susceptibility to induced colitis | "increased severity or induction threshold of colitis upon treatment of an organism with intestinal inflammation agents such as dextran sodium sulfate (DSS)" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ap1s2tm1Pschu/Y
Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
| MP:0008560 | increased tumor necrosis factor secretion | "increase in the production or release of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: Ap1s2tm1Pschu/Y
Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
| MP:0008568 | abnormal interleukin secretion | "anomaly in the production or cellular release of soluble factors which stimulate growth-related activities of leukocytes and other cell types, that can act to enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli" [MESH:D12.644.276.374.465] |
Show
Allelic Composition: Ap1s2tm1Pschu/Y
Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
| MP:0008657 | increased interleukin-1 beta secretion | "increase in the production or release of an interleukin-1 subtype that is synthesized as an inactive membrane-bound pro-protein on monocytes, macrophages and other cells; proteolytic processing of the precursor form by caspase 1 results in release of the active form of interleukin-1beta from the membrane" [MESH:D12.644.276.374.465.501.600] |
Show
Allelic Composition: Ap1s2tm1Pschu/Y
Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
| MP:0008672 | increased interleukin-13 secretion | "increase in the production or release of a cytokine synthesized by T-cells that produces proliferation, immunoglobulin isotype switching, and immunoglobulin production by immature B-cells, and appears to play a role in regulating inflammatory and immune responses" [MESH:D12.644.276.374.465.513] |
Show
Allelic Composition: Ap1s2tm1Pschu/Y
Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
| MP:0008700 | decreased interleukin-4 secretion | "reduction in the production or release of a soluble factor produced by activated T-cells that induces the expression of MHC class II genes and FC receptors on B-cells and causes their proliferation and differentiation; it also acts on T-cells, mast cells and several other hematopoietic lineage cells" [MESH:D12.644.276.374.465.504] |
Show
Allelic Composition: Ap1s2tm1Pschu/Y
Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
| MP:0008702 | increased interleukin-5 secretion | "increase in the production or release of a cytokine that promotes differentiation and activation of eosinophils; it also triggers activated B-cells to differentiate into immunoglobulin-secreting cells" [MESH:D12.644.276.374.465.505] |
Show
Allelic Composition: Ap1s2tm1Pschu/Y
Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
| MP:0008705 | increased interleukin-6 secretion | "increase in the production or release of a cytokine that stimulates the growth and differentiation of B-cells and is also a growth factor for hybridomas and plasmacytomas, and is produced by many different cells including T-cells, monocytes and fibroblasts" [MESH:D12.644.276.374.465.506] |
Show
Allelic Composition: Ap1s2tm1Pschu/Y
Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
| MP:0008722 | abnormal chemokine secretion | "anomaly in the production or cellular release of any of the class of pro-inflammatory cytokines that attract and activate leukocytes" [MESH:D12.644.276.374.200] |
Show
Allelic Composition: Ap1s2tm1Pschu/Y
Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
| MP:0010180 | increased susceptibility to weight loss | "greater decrease in body weight over time when compared to the average decrease in weight in response to dietary modification, fasting or caloric restriction" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ap1s2tm1Pschu/Y
Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
